Results 151 to 160 of about 83,082 (294)
E. faecalis was the predominant species (60.7%). Moreover, 39.3% of the isolates were identified as VRE with an MIC > 32 μg/mL, and the vanA gene was detected in 35.7% of the isolates. High‐level resistance to gentamicin and streptomycin was observed in 60.7% and 50% of the isolates, respectively.
Maryam Koleini+3 more
wiley +1 more source
Claudin 18.2: a promising actionable target in biliary tract cancers. [PDF]
Angerilli V+13 more
europepmc +1 more source
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma
ABSTRACT Background Recent studies addressing the role of adjuvant chemotherapy (AC) in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability.
Yoon Soo Chae+9 more
wiley +1 more source
Impact of Bone Metastases and Actionable Genetic Alterations in Biliary Tract Cancer. [PDF]
El-Shakankery KH+4 more
europepmc +1 more source
131I-Rose Bengal Test before and after Operation of Biliary Tract Diseases
Kazuo ISHIYAMA+4 more
openalex +2 more sources
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections [PDF]
Michel G. Bergeron+9 more
openalex +1 more source
ABSTRACT Background/Purpose Current guidelines do not provide specific recommendations regarding the timing of endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute cholangitis (AC) concurrent with acute gallstone pancreatitis (AGP). This study evaluated the impact of ERCP timing on clinical outcomes.
Mustafa Comoglu+6 more
wiley +1 more source
Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer. [PDF]
Hu Y+7 more
europepmc +1 more source